Leave a Message
Articles

Weighing the Risks and Benefits of Chronic Opioid Therapy

ANNA LEMBKE, KEITH HUMPHREYS, JORDAN NEWMARK

When considering chronic opioid therapy, physicians should weigh the risks against any possible benefits and should assess for the risks of opioid misuse, opioid use disorder, and overdose. When initiating opioid therapy, physicians should consider buprenorphine for patients...

Evaluation of the Painful Eye

MATTHEW PFLIPSEN, MARIAMA MASSAQUOI, SUZANNE WOLF

The evaluation of eye pain includes an assessment of visual acuity and a systematic evaluation of the conjunctiva, eyelids, sclera, cornea, pupil, anterior chamber, and anterior uvea. Further examination with fluorescein staining and tonometry is often necessary. Because pain...

AAFP News Now: AFP Edition

AAFP News: AFP Edition

CMS Says It's Prepared to Help Small Practices Navigate MACRA Changes | Family Physician Salaries Increase, but Still Trail Those of Other Subspecialists | Free Webinar Addresses Influenza Vaccination in Older Adults | Harvard Medical School Takes Case Study Approach to...

Editorials

Using the CDC Guideline and Tools for Opioid Prescribing in Patients with Chronic Pain

DEBORAH DOWELL, TAMARA M. HAEGERICH

The new CDC guideline is intended to help clinicians decide whether and how to prescribe opioids for chronic pain; offer safer, more effective care for patients with chronic pain; improve clinician-patient communication; and prevent opioid use disorder and opioid-related...

The Opioid Epidemic: AMA's Response

PATRICE A. HARRIS

The opioid epidemic that is afflicting our nation resulted in nearly 30,000 deaths last year. Those of us responsible for health care and policy are looking at ways to stop these needless deaths. It is our professional and ethical responsibility as physicians to help bring...

Point-of-Care Guides

Rapid Protocols to Rule out Myocardial Infarction

MARK H. EBELL

Cardiac troponin T and I are released into the bloodstream when cardiac muscle is damaged. Cardiac troponin tests have been available for decades and are the preferred biomarkers for the diagnosis of acute myocardial infarction (AMI). However, until recently, they lacked...

STEPS

Suvorexant (Belsomra) for Insomnia

ANDREA R. GAULD

Suvorexant effectively increases total sleep time and decreases time to sleep onset. Because of its risk of abuse, significant incidence of next-day impairment, and high cost, it should be reserved for use in patients for whom other insomnia therapies, such as cognitive...

Photo Quiz Putting Prevention Into Practice

Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus

QUYEN NGO-METZGER, JOHN OWINGS

M.A. is a 43-year-old woman with a seven pack-year smoking history. She has no health concerns and has not visited a physician in four years. Her blood pressure and pulse are normal, and her body mass index (BMI) is 27 kg per m2. She does not have a family history of diabetes...

POEMs

Chondroitin/Glucosamine Equal to Celecoxib for Knee Osteoarthritis

ALLEN F. SHAUGHNESSY

or patients with painful knee osteoarthritis, a high-dose combination of glucosamine hydrochloride (1,500 mg) and chondroitin (1,200 mg) was as effective in lessening pain and stiffness and improving function as celecoxib (200 mg). Other studies have not found benefit.

Practice Guidelines

CDC Develops Guideline for Opioid Prescribing

MARSELLE BREDEMEYER

A recently released guideline aims to establish patient-centered approaches to initiating, managing, and discontinuing opioid use. The recommendations from the Centers for Disease Control and Prevention (CDC) emphasize the serious risks and harms associated with opioids.

U.S. Preventive Services Task Force Information from Your Family Doctor


Disclosure

All editors in a position to control content for this activity, AFP journal, are required to disclose any relevant financial relationships. View disclosures.


Tag Legend

Legend

CME Continuing Medical Education Credit
POC Point-of-Care Resource
FREE Free Access
Alg Algorithm
DDx Differential Diagnosis
PtEd Patient Education